Gülnaz Kervancioğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gülnaz Kervancioğlu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Elif Kervancioglu Demirci
Histology and Embryology Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
1 shared publication - Gulderen Sahin
Department of Physiology, İstanbul Aydın University Faculty of Medicine, İstanbul, Türkiye
1 shared publication - Ibrahim Guner
Department of Physiology, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Türkiye
1 shared publication - Muhittin Onur Yaman
Department of Medical Services and Techniques, İstanbul University-Cerrahpaşa Vocational School of Health Services, Istanbul, Türkiye
1 shared publication - Musab Işık
Department of Physiology, İstanbul Aydın University Faculty of Medicine, İstanbul, Türkiye
1 shared publication - Nermin Yelmen
Department of Physiology, İstanbul Aydın University Faculty of Medicine, İstanbul, Türkiye
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (12) , 19139-19155
Fluoxetine attenuates hepatic ischemia–reperfusion injury through antioxidant, anti-inflammatory and anti-apoptotic mechanisms
Hepatic ischemia–reperfusion injury is a major clinical problem associated with liver surgery, trauma, and transplantation, characterized by oxidative stress, inflammation, microcirculatory dysfunction, and apoptosis. Fluoxetine, a selective serotonin reuptake inhibitor, has been reported to exert antioxidant, anti-inflammatory, and antiapoptotic effects. The present study aimed to investigate the potential protective effects of fluoxetine against experimental hepatic ischemia–reperfusion injury in rats. Male Wistar rats were randomly assigned to three groups: control, ischemia–reperfusion and fluoxetine-treated ischemia–reperfusion ( n = 7 each). Hepatic ischemia–reperfusion injury was induced by infrarenal abdominal aortic cross-clamping for 60 min followed by 120 min of reperfusion. Fluoxetine (20 mg/kg/day, intraperitoneal) was administered for three consecutive days prior to ischemia. Oxidative stress markers, antioxidant parameters, inflammatory and anti-inflammatory cytokines, apoptotic markers, and specific tissue injury biomarkers were measured in liver homogenates using ELISA. Histopathological alterations were evaluated by light microscopy. Ischemia–reperfusion significantly increased oxidant markers, inflammatory cytokines, NF-κB activation, apoptotic indices, liver enzyme levels, and histological damage, while reducing antioxidant capacity. Fluoxetine treatment markedly restored antioxidant defenses, suppressed oxidative stress, inflammation, apoptosis, and microcirculatory injury, and significantly improved histopathological findings compared with the untreated ischemia–reperfusion group. Fluoxetine exerts a protective effect against hepatic ischemia–reperfusion injury through antioxidant, anti-inflammatory and antiapoptotic mechanisms, suggesting its potential as a therapeutic agent in conditions associated with hepatic ischemia–reperfusion.
- 19 June 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (12) , 19139-19155
Open AccessFluoxetine attenuates hepatic ischemia–reperfusion injury through antioxidant, anti-inflammatory and anti-apoptotic mechanisms
Hepatic ischemia–reperfusion injury is a major clinical problem associated with liver surgery, trauma, and transplantation, characterized by oxidative stress, inflammation, microcirculatory dysfunction, and apoptosis. Fluoxetine, a selective serotonin reuptake inhibitor, has been reported to exert antioxidant, anti-inflammatory, and antiapoptotic effects. The present study aimed to investigate the potential protective effects of fluoxetine against experimental hepatic ischemia–reperfusion injury in rats. Male Wistar rats were randomly assigned to three groups: control, ischemia–reperfusion and fluoxetine-treated ischemia–reperfusion ( n = 7 each). Hepatic ischemia–reperfusion injury was induced by infrarenal abdominal aortic cross-clamping for 60 min followed by 120 min of reperfusion. Fluoxetine (20 mg/kg/day, intraperitoneal) was administered for three consecutive days prior to ischemia. Oxidative stress markers, antioxidant parameters, inflammatory and anti-inflammatory cytokines, apoptotic markers, and specific tissue injury biomarkers were measured in liver homogenates using ELISA. Histopathological alterations were evaluated by light microscopy. Ischemia–reperfusion significantly increased oxidant markers, inflammatory cytokines, NF-κB activation, apoptotic indices, liver enzyme levels, and histological damage, while reducing antioxidant capacity. Fluoxetine treatment markedly restored antioxidant defenses, suppressed oxidative stress, inflammation, apoptosis, and microcirculatory injury, and significantly improved histopathological findings compared with the untreated ischemia–reperfusion group. Fluoxetine exerts a protective effect against hepatic ischemia–reperfusion injury through antioxidant, anti-inflammatory and antiapoptotic mechanisms, suggesting its potential as a therapeutic agent in conditions associated with hepatic ischemia–reperfusion.
- 30 March 2022
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 12 (1) , 268-273
Current Approach to Spermatogonial Stem Cells in Vitro Maturation
The studies conducted to determine the stage of its usability in prospective fertility restoration of testicular tissues taken from prepubertal patients undergoing oncology treatment were screened. In addition, the current status of spermatogonial stem cell cultures, testicular tissue cultures, and testicular organoid research and their potential in fertility restoration were examined. Spermatogonial stem cells are only found in prepubertal testicular tissue. Germinal serial cells are not found. Since spermatozoa are not produced in this period, spermatogonial stem cells are stored by freezing in the form of testicular tissue pieces or testicular cell suspension. It is not yet clear how to ensure the maturation of freeze-thawed or fresh spermatogonial stem cells for fertility reconstruction when it is necessary. The spermatogonial stem cells can be placed in their original niche by maintaining the vitality of the seminiferous tubules in vitro. Then, it can be transplanted to the recipient. Many hypotheses suggested that that maturation can be achieved via such as two-dimensional, three-dimensional tissue cultures. To ensure differentiation and proliferation of spermatogonial stem cells in three-dimensional cultures, it is necessary to ensure the long-term viability of the seminiferous tubules in vitro or solve creating an environment similar to the seminiferous tubules niche. In this review article, spermatozoa could be obtained in three-dimensional culture. However, the application of this system in different laboratories and the provision of the setup involves various difficulties. Standard organoids and organoid scaffolds that can be developed for three-dimensional cultures seem to be more preferable.
- 30 March 2022
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 12 (1) , 268-273
Current Approach to Spermatogonial Stem Cells in Vitro Maturation
The studies conducted to determine the stage of its usability in prospective fertility restoration of testicular tissues taken from prepubertal patients undergoing oncology treatment were screened. In addition, the current status of spermatogonial stem cell cultures, testicular tissue cultures, and testicular organoid research and their potential in fertility restoration were examined. Spermatogonial stem cells are only found in prepubertal testicular tissue. Germinal serial cells are not found. Since spermatozoa are not produced in this period, spermatogonial stem cells are stored by freezing in the form of testicular tissue pieces or testicular cell suspension. It is not yet clear how to ensure the maturation of freeze-thawed or fresh spermatogonial stem cells for fertility reconstruction when it is necessary. The spermatogonial stem cells can be placed in their original niche by maintaining the vitality of the seminiferous tubules in vitro. Then, it can be transplanted to the recipient. Many hypotheses suggested that that maturation can be achieved via such as two-dimensional, three-dimensional tissue cultures. To ensure differentiation and proliferation of spermatogonial stem cells in three-dimensional cultures, it is necessary to ensure the long-term viability of the seminiferous tubules in vitro or solve creating an environment similar to the seminiferous tubules niche. In this review article, spermatozoa could be obtained in three-dimensional culture. However, the application of this system in different laboratories and the provision of the setup involves various difficulties. Standard organoids and organoid scaffolds that can be developed for three-dimensional cultures seem to be more preferable.